Dr. Duncan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# 4
Pittsburgh, PA 15213Phone+1 412-648-6161
Education & Training
- UPMC Medical EducationResidency, Internal Medicine, 1984 - 1985
- University of WashingtonResidency, Internal Medicine, 1981 - 1984
- University of Washington School of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1985 - Present
- AL State Medical License 2015 - 2024
- PA State Medical License 1984 - 2024
- WA State Medical License 1982 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2003 Jan 01
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry Start of enrollment: 2003 Oct 01
- A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 144 citationsStatin Use Is Associated with Improved Function and Survival of Lung AllograftsB.A. Johnson, Aldo Iacono, Adriana Zeevi, Kenneth R. McCurry, Steven R. Duncan
American Journal of Respiratory and Critical Care Medicine. 2003-05-01 - 121 citationsPlasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis PatientsJianmin Xue, Daniel J. Kass, Jessica Bon, Louis J. Vuga, Jiangning Tan
Journal of Immunology. 2013-09-01 - 19 citationsPlasma Inflammatory Mediators Associated with Bone Metabolism in COPDJessica Bon, Yingze Zhang, Steven R. Duncan, Joseph M. Pilewski, Diana Zaldonis
COPD. 2010-05-20
Press Mentions
- Pandemic Means EveryoneMarch 24th, 2020
- UAB Receives $8.9 Million Grant to Continue Testing of New Drug for IPFAugust 23rd, 2018
- Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPFJuly 17th, 2019
Grant Support
- The Role Of Humoral Autoimmunity In Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2011–2012
- Clonal CD4 T-Cells In Lung Transplant RecipientsNational Heart, Lung, And Blood Institute2006–2009
- Dendritic Cells For Induction Of Allograft ToleranceNational Heart, Lung, And Blood Institute2001–2003
- Dendritic Cells For Induction Of Allograft ToleranceNational Heart, Lung, And Blood Institute2000
- Rejection And Tolerance Of Respiratory Tract AllograftsNational Heart, Lung, And Blood Institute1995–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: